Grant Program
The Friedreich's Ataxia Research Alliance (FARA) is dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's ataxia. FARA supports research through funding competitive grants, promoting collaboration between scientists, advocating for public-private partnerships that support drug development and clinical research and hosting open forums for leading scientists to share their insights, ideas and challenges to advancing treatments for FA.
FARA has provided more than 10 million in research funding over the past 10 years to scientists in both public and private organizations. In the early years funding priorities were focused on understanding the cause of FA and the pathophysiology underlying the disease. While there is still more to learn about the intricacies of this disease we have expanded our focus to translational and clinical research.
FARA’s Grant Program Priorities
- Advance drug discovery and have a diverse treatment pipeline
- Facilitate the drug development process and translational research so that the most promising discoveries are rapidly brought to treatment trials
- Support the clinical research, infrastructure and biomarker discovery required to ensure effective and efficient clinical trials in a rare disease
- Support young/new researchers with innovative ideas and a commitment to FA research
- Reduce the morbidity and mortality caused by cardiac disease in FA
Types of Grants Offered to Qualified Researchers
